Neuralstem

CUR NASDAQ
4.550
-0.300
-6.19%
After Hours: 4.870 +0.32 +7.03% 18:44 07/23 EDT
Open
4.750
Prev Close
4.850
High
4.750
Low
4.250
Volume
171.12K
Avg Vol (3M)
30.69K
52 Week High
31.80
52 Week Low
4.250
% Turnover
17.10%
Market Cap
4.55M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Neuralstem CUR stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Neuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform. The Company's technology allows the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the treatment of central nervous system diseases and conditions. The Company is developing NSI-189 for the treatment of major depressive disorder (MDD) and other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy. The Company's NSI-566 is indicated for amyotrophic lateral sclerosis (ALS), chronic spinal cord injury and motor deficits due to ischemic stroke.
MORE >

Recently

Name
Price
%Change